#365of 1,000 in 2025

FOXG1 Research Inc

Location
Sands Point, New York
Sector
Disease and medical
Founded
2018
485%Three-year growth, FY2022 to FY2025
$5.7MFY2025 revenue
0Employees, FY2025
#4of 11 in Disease and medical
#15of 52 in New York

Revenue by fiscal year

FY2022: $979,751 $980K FY22 FY2023: $1,660,440 $1.7M FY23 FY2024: $4,910,861 $4.9M FY24 FY2025: $5,733,828 $5.7M FY25

We count pledges when the cash is received, not when they’re promised, so these numbers differ from FOXG1 Research Inc’s 990. How we count pledges

Where revenue came from, FY2025

Gifts and grants
$5.5M · 96%
Program revenue
$139K · 2%
Noncash gifts
$116K · 2%
Other revenue
− $5K
Total revenue on the 990
$6,865,223
Investment income
− $131,395
Pledges promised this year, not yet received
− $1,000,000
Revenue we count
$5,733,828

What it does

Find a cure, find treatments, provide therapeutics, advocating for patients, and supporting families for FOXG1 Syndrome.

Fund research to find a cure.

Leadership

Nicole JohnsonExecutive Director

EIN 82-5300929 · Full filings on ProPublica

Want to share your story?

We’d love to hear your story of growth.

Share your story